RAI Lebanon is a medicare approved dialysis facility center in Lebanon, Tennessee and it has 17 dialysis stations. It is located in Wilson county at 1701 W. Main Street, Lebanon, TN, 37087. You can reach out to the office of RAI Lebanon at (615) 449-5651. This dialysis clinic is managed and/or owned by Fresenius Medical Care. RAI Lebanon has the following ownership type - Profit. It was first certified by medicare in December, 2010. The medicare id for this facility is 442705 and it accepts patients under medicare ESRD program.
| Name | RAI Lebanon |
|---|---|
| Location | 1701 W. Main Street, Lebanon, Tennessee |
| No. of Dialysis Stations | 17 |
| Medicare ID | 442705 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 1701 W. Main Street, Lebanon, Tennessee, 37087 | |
| (615) 449-5651 | |
News Archive
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced NTT DATA, its strategic partner in Japan, has signed its first Enterprise Transfer client.
INC Research ®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, has created an Alliance Partnerships program dedicated to the creation and management of strategic clinical delivery alliances with pharmaceutical and biotechnology customers. Tim Dietlin has been appointed VP, Alliance Development to lead this effort on structuring alliance relationships based on joint strategic objectives rather than service level agreements.
More than 1,000 researchers, government officials and advocates are gathering in Atlanta this week to discuss the progress and future challenges in the development of a vaccine that protects against HIV, FierceVaccines reports (Carroll, 9/29). The AIDS Vaccine 2010 meeting, which kicked off Tuesday, will run through Friday, according to the website for the meeting (undated).
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
The results of a new Creighton University study may soon spell relief for some of the estimated 40 million Americans who suffer from seasonal allergic rhinitis (SAR) caused by pollens such as grass and ragweed.
› Verified 9 days ago
| NPI Number | 1770810293 |
| Organization Name | Rai-main St-lebanon |
| Doing Business As | Rai Care Centers Of Lebanon I Llc |
| Address | 1701 West Main Street Lebanon, Tennessee, 37087 |
| Phone Number | (615) 661-1100 |
News Archive
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced NTT DATA, its strategic partner in Japan, has signed its first Enterprise Transfer client.
INC Research ®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, has created an Alliance Partnerships program dedicated to the creation and management of strategic clinical delivery alliances with pharmaceutical and biotechnology customers. Tim Dietlin has been appointed VP, Alliance Development to lead this effort on structuring alliance relationships based on joint strategic objectives rather than service level agreements.
More than 1,000 researchers, government officials and advocates are gathering in Atlanta this week to discuss the progress and future challenges in the development of a vaccine that protects against HIV, FierceVaccines reports (Carroll, 9/29). The AIDS Vaccine 2010 meeting, which kicked off Tuesday, will run through Friday, according to the website for the meeting (undated).
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
The results of a new Creighton University study may soon spell relief for some of the estimated 40 million Americans who suffer from seasonal allergic rhinitis (SAR) caused by pollens such as grass and ragweed.
› Verified 9 days ago
| Dialysis patients with Hemoglobin data | 30 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 20 |
News Archive
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced NTT DATA, its strategic partner in Japan, has signed its first Enterprise Transfer client.
INC Research ®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, has created an Alliance Partnerships program dedicated to the creation and management of strategic clinical delivery alliances with pharmaceutical and biotechnology customers. Tim Dietlin has been appointed VP, Alliance Development to lead this effort on structuring alliance relationships based on joint strategic objectives rather than service level agreements.
More than 1,000 researchers, government officials and advocates are gathering in Atlanta this week to discuss the progress and future challenges in the development of a vaccine that protects against HIV, FierceVaccines reports (Carroll, 9/29). The AIDS Vaccine 2010 meeting, which kicked off Tuesday, will run through Friday, according to the website for the meeting (undated).
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
The results of a new Creighton University study may soon spell relief for some of the estimated 40 million Americans who suffer from seasonal allergic rhinitis (SAR) caused by pollens such as grass and ragweed.
› Verified 9 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 55 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 406 |
| Percentage of adult patients getting regular hemodialysis at the center | 96 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced NTT DATA, its strategic partner in Japan, has signed its first Enterprise Transfer client.
INC Research ®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, has created an Alliance Partnerships program dedicated to the creation and management of strategic clinical delivery alliances with pharmaceutical and biotechnology customers. Tim Dietlin has been appointed VP, Alliance Development to lead this effort on structuring alliance relationships based on joint strategic objectives rather than service level agreements.
More than 1,000 researchers, government officials and advocates are gathering in Atlanta this week to discuss the progress and future challenges in the development of a vaccine that protects against HIV, FierceVaccines reports (Carroll, 9/29). The AIDS Vaccine 2010 meeting, which kicked off Tuesday, will run through Friday, according to the website for the meeting (undated).
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
The results of a new Creighton University study may soon spell relief for some of the estimated 40 million Americans who suffer from seasonal allergic rhinitis (SAR) caused by pollens such as grass and ragweed.
› Verified 9 days ago
| Adult patients getting regular peritoneal dialysis at the center | 12 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 71 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 99 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced NTT DATA, its strategic partner in Japan, has signed its first Enterprise Transfer client.
INC Research ®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, has created an Alliance Partnerships program dedicated to the creation and management of strategic clinical delivery alliances with pharmaceutical and biotechnology customers. Tim Dietlin has been appointed VP, Alliance Development to lead this effort on structuring alliance relationships based on joint strategic objectives rather than service level agreements.
More than 1,000 researchers, government officials and advocates are gathering in Atlanta this week to discuss the progress and future challenges in the development of a vaccine that protects against HIV, FierceVaccines reports (Carroll, 9/29). The AIDS Vaccine 2010 meeting, which kicked off Tuesday, will run through Friday, according to the website for the meeting (undated).
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
The results of a new Creighton University study may soon spell relief for some of the estimated 40 million Americans who suffer from seasonal allergic rhinitis (SAR) caused by pollens such as grass and ragweed.
› Verified 9 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at RAI Lebanon with elevated calcium levels.
| Patients with hypercalcemia | 68 |
| Hypercalcemia patient months | 508 |
| Patients with Serumphosphor | 73 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 32 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 31 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 18 |
| Patients with Serumphosphor greater than 7 mg/dL | 10 |
News Archive
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced NTT DATA, its strategic partner in Japan, has signed its first Enterprise Transfer client.
INC Research ®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, has created an Alliance Partnerships program dedicated to the creation and management of strategic clinical delivery alliances with pharmaceutical and biotechnology customers. Tim Dietlin has been appointed VP, Alliance Development to lead this effort on structuring alliance relationships based on joint strategic objectives rather than service level agreements.
More than 1,000 researchers, government officials and advocates are gathering in Atlanta this week to discuss the progress and future challenges in the development of a vaccine that protects against HIV, FierceVaccines reports (Carroll, 9/29). The AIDS Vaccine 2010 meeting, which kicked off Tuesday, will run through Friday, according to the website for the meeting (undated).
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
The results of a new Creighton University study may soon spell relief for some of the estimated 40 million Americans who suffer from seasonal allergic rhinitis (SAR) caused by pollens such as grass and ragweed.
› Verified 9 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 50 |
| Patient months included in arterial venous fistula and catheter summaries | 313 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 42 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 27 |
News Archive
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced NTT DATA, its strategic partner in Japan, has signed its first Enterprise Transfer client.
INC Research ®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, has created an Alliance Partnerships program dedicated to the creation and management of strategic clinical delivery alliances with pharmaceutical and biotechnology customers. Tim Dietlin has been appointed VP, Alliance Development to lead this effort on structuring alliance relationships based on joint strategic objectives rather than service level agreements.
More than 1,000 researchers, government officials and advocates are gathering in Atlanta this week to discuss the progress and future challenges in the development of a vaccine that protects against HIV, FierceVaccines reports (Carroll, 9/29). The AIDS Vaccine 2010 meeting, which kicked off Tuesday, will run through Friday, according to the website for the meeting (undated).
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
The results of a new Creighton University study may soon spell relief for some of the estimated 40 million Americans who suffer from seasonal allergic rhinitis (SAR) caused by pollens such as grass and ragweed.
› Verified 9 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 50 |
| Hospitalization Rate in facility | 296.9 (Worse than Expected) |
| Hospitalization Rate: Upper Confidence Limit | 470.2 |
| Hospitalization Rate: Lower Confidence Limit | 193.7 |
News Archive
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced NTT DATA, its strategic partner in Japan, has signed its first Enterprise Transfer client.
INC Research ®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, has created an Alliance Partnerships program dedicated to the creation and management of strategic clinical delivery alliances with pharmaceutical and biotechnology customers. Tim Dietlin has been appointed VP, Alliance Development to lead this effort on structuring alliance relationships based on joint strategic objectives rather than service level agreements.
More than 1,000 researchers, government officials and advocates are gathering in Atlanta this week to discuss the progress and future challenges in the development of a vaccine that protects against HIV, FierceVaccines reports (Carroll, 9/29). The AIDS Vaccine 2010 meeting, which kicked off Tuesday, will run through Friday, according to the website for the meeting (undated).
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
The results of a new Creighton University study may soon spell relief for some of the estimated 40 million Americans who suffer from seasonal allergic rhinitis (SAR) caused by pollens such as grass and ragweed.
› Verified 9 days ago
The rate of readmission show you whether patients who were being treated regularly at RAI Lebanon were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 31 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 45.6 |
| Readmission Rate: Lower Confidence Limit | 18.7 |
News Archive
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced NTT DATA, its strategic partner in Japan, has signed its first Enterprise Transfer client.
INC Research ®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, has created an Alliance Partnerships program dedicated to the creation and management of strategic clinical delivery alliances with pharmaceutical and biotechnology customers. Tim Dietlin has been appointed VP, Alliance Development to lead this effort on structuring alliance relationships based on joint strategic objectives rather than service level agreements.
More than 1,000 researchers, government officials and advocates are gathering in Atlanta this week to discuss the progress and future challenges in the development of a vaccine that protects against HIV, FierceVaccines reports (Carroll, 9/29). The AIDS Vaccine 2010 meeting, which kicked off Tuesday, will run through Friday, according to the website for the meeting (undated).
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
The results of a new Creighton University study may soon spell relief for some of the estimated 40 million Americans who suffer from seasonal allergic rhinitis (SAR) caused by pollens such as grass and ragweed.
› Verified 9 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at RAI Lebanon get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .23 (As Expected) |
| SIR: Upper Confidence Limit | 1.11 |
| SIR: Lower Confidence Limit | .01 |
News Archive
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced NTT DATA, its strategic partner in Japan, has signed its first Enterprise Transfer client.
INC Research ®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, has created an Alliance Partnerships program dedicated to the creation and management of strategic clinical delivery alliances with pharmaceutical and biotechnology customers. Tim Dietlin has been appointed VP, Alliance Development to lead this effort on structuring alliance relationships based on joint strategic objectives rather than service level agreements.
More than 1,000 researchers, government officials and advocates are gathering in Atlanta this week to discuss the progress and future challenges in the development of a vaccine that protects against HIV, FierceVaccines reports (Carroll, 9/29). The AIDS Vaccine 2010 meeting, which kicked off Tuesday, will run through Friday, according to the website for the meeting (undated).
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
The results of a new Creighton University study may soon spell relief for some of the estimated 40 million Americans who suffer from seasonal allergic rhinitis (SAR) caused by pollens such as grass and ragweed.
› Verified 9 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether RAI Lebanon's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 45 |
| Transfusion Rate in facility | 57.6 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 139.2 |
| Transfusion Rate: Lower Confidence Limit | 26.5 |
News Archive
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced NTT DATA, its strategic partner in Japan, has signed its first Enterprise Transfer client.
INC Research ®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, has created an Alliance Partnerships program dedicated to the creation and management of strategic clinical delivery alliances with pharmaceutical and biotechnology customers. Tim Dietlin has been appointed VP, Alliance Development to lead this effort on structuring alliance relationships based on joint strategic objectives rather than service level agreements.
More than 1,000 researchers, government officials and advocates are gathering in Atlanta this week to discuss the progress and future challenges in the development of a vaccine that protects against HIV, FierceVaccines reports (Carroll, 9/29). The AIDS Vaccine 2010 meeting, which kicked off Tuesday, will run through Friday, according to the website for the meeting (undated).
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
The results of a new Creighton University study may soon spell relief for some of the estimated 40 million Americans who suffer from seasonal allergic rhinitis (SAR) caused by pollens such as grass and ragweed.
› Verified 9 days ago
The rate of mortality show you whether patients who were being treated regularly at RAI Lebanon lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 223 |
| Mortality Rate in facility | 17.8 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 24.9 |
| Mortality Rate: Lower Confidence Limit | 12.3 |
News Archive
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced NTT DATA, its strategic partner in Japan, has signed its first Enterprise Transfer client.
INC Research ®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, has created an Alliance Partnerships program dedicated to the creation and management of strategic clinical delivery alliances with pharmaceutical and biotechnology customers. Tim Dietlin has been appointed VP, Alliance Development to lead this effort on structuring alliance relationships based on joint strategic objectives rather than service level agreements.
More than 1,000 researchers, government officials and advocates are gathering in Atlanta this week to discuss the progress and future challenges in the development of a vaccine that protects against HIV, FierceVaccines reports (Carroll, 9/29). The AIDS Vaccine 2010 meeting, which kicked off Tuesday, will run through Friday, according to the website for the meeting (undated).
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
The results of a new Creighton University study may soon spell relief for some of the estimated 40 million Americans who suffer from seasonal allergic rhinitis (SAR) caused by pollens such as grass and ragweed.
› Verified 9 days ago
News Archive
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced NTT DATA, its strategic partner in Japan, has signed its first Enterprise Transfer client.
INC Research ®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, has created an Alliance Partnerships program dedicated to the creation and management of strategic clinical delivery alliances with pharmaceutical and biotechnology customers. Tim Dietlin has been appointed VP, Alliance Development to lead this effort on structuring alliance relationships based on joint strategic objectives rather than service level agreements.
More than 1,000 researchers, government officials and advocates are gathering in Atlanta this week to discuss the progress and future challenges in the development of a vaccine that protects against HIV, FierceVaccines reports (Carroll, 9/29). The AIDS Vaccine 2010 meeting, which kicked off Tuesday, will run through Friday, according to the website for the meeting (undated).
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute.
The results of a new Creighton University study may soon spell relief for some of the estimated 40 million Americans who suffer from seasonal allergic rhinitis (SAR) caused by pollens such as grass and ragweed.
› Verified 9 days ago